quinoxalines and quinpirole

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cocaine; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Glutamine; Injections; Kainic Acid; Male; Motor Activity; Nerve Endings; Nucleus Accumbens; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid

Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Drug Interactions; Ergolines; Haloperidol; Levodopa; Male; Pilot Projects; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Brimonidine Tartrate; Calcium; Dopamine Agents; Ergolines; Fenoldopam; Humans; In Vitro Techniques; Indoles; Kidney Cortex; Middle Aged; Norepinephrine; Oxidopamine; Pyridines; Quinoxalines; Quinpirole; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Ergolines; Male; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Substantia Nigra; Synaptic Membranes; Tetrodotoxin

Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Binding, Competitive; Brimonidine Tartrate; Dopamine; Electric Stimulation; Ergolines; GTP-Binding Proteins; Haloperidol; In Vitro Techniques; Male; Nucleus Accumbens; Pergolide; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Signal Transduction; Sulpiride

Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Benzazepines; Brimonidine Tartrate; Domperidone; Dopamine Agonists; Dopamine Antagonists; Electric Stimulation; Ergolines; Female; Fenoldopam; Heart Atria; Humans; In Vitro Techniques; Male; Methoxamine; Middle Aged; Norepinephrine; Prazosin; Quinoxalines; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Dopamine; Sulpiride; Synaptic Transmission; Yohimbine

Topics: 2-Amino-5-phosphonovalerate; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electric Stimulation; Excitatory Amino Acid Antagonists; Frontal Lobe; Nerve Fibers; Organ Culture Techniques; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Tetrodotoxin

Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzazepines; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Membrane Potentials; Prefrontal Cortex; Pyramidal Cells; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Flupenthixol; Injections, Intraventricular; Male; Movement; Nucleus Accumbens; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Baclofen; Brimonidine Tartrate; Calcium; Cyclic AMP; Dopamine Agonists; Drug Interactions; Excitatory Amino Acid Agonists; GABA Agonists; GTP-Binding Protein alpha Subunits, Gi-Go; Hippocampus; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Quinoxalines; Quinpirole; Radioimmunoassay; Receptors, G-Protein-Coupled; Receptors, N-Methyl-D-Aspartate; Serotonin Receptor Agonists

Topics: Animals; Animals, Newborn; Cerebral Cortex; Dopamine Agonists; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; Globus Pallidus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neural Pathways; Patch-Clamp Techniques; Piperazines; Presynaptic Terminals; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D2; Synapses

Topics: Animals; Biophysics; Chelating Agents; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Egtazic Acid; Electric Stimulation; Electrochemistry; Excitatory Amino Acid Antagonists; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GABA Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred DBA; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Propanolamines; Quinoxalines; Quinpirole; Rhodamines; Signal Transduction; Statistics, Nonparametric; Temperature; Time Factors; Ventral Tegmental Area

Topics: Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Cocaine; Conditioning, Operant; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Neurotransmitter Agents; Norepinephrine; Patch-Clamp Techniques; Quinoxalines; Quinpirole; Rats; Rats, Long-Evans; Reinforcement Schedule; Self Administration; Septal Nuclei; Synaptic Potentials; Yohimbine

Topics: Animals; Biophysics; Channelrhodopsins; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Luminescent Proteins; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neural Pathways; Neurons; Patch-Clamp Techniques; Quinoxalines; Quinpirole; Tyrosine 3-Monooxygenase; Ventral Tegmental Area; Vesicular Glutamate Transport Protein 2

Topics: Age Factors; Analysis of Variance; Anesthetics, Local; Animals; Biophysics; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Exploratory Behavior; Female; GABA Agents; Green Fluorescent Proteins; Hindlimb Suspension; In Vitro Techniques; Interneurons; Lidocaine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neural Inhibition; Neuronal Plasticity; Patch-Clamp Techniques; Pregnancy; Prenatal Exposure Delayed Effects; Quinoxalines; Quinpirole; Receptors, GABA-A; Rotarod Performance Test; Sodium Channel Blockers; Statistics, Nonparametric; Tetrodotoxin

Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Calcium Channels; Cocaine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABAergic Neurons; Glutamic Acid; Habenula; Male; Miniature Postsynaptic Potentials; Piperazines; Quinoxalines; Quinpirole; Raclopride; Rats; Receptors, Dopamine; Receptors, Glutamate; Sodium Channels; Synaptic Transmission

Topics: Amygdala; Animals; Benzazepines; Choice Behavior; Conditioning, Operant; Drug Therapy, Combination; Glutamic Acid; Male; Medial Forebrain Bundle; Nucleus Accumbens; Quinoxalines; Quinpirole; Rats; Receptors, AMPA; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Self Stimulation

Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Clozapine; Dopaminergic Neurons; Ethanol; gamma-Aminobutyric Acid; Male; Microinjections; Neural Inhibition; Neural Pathways; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Quinoxalines; Quinpirole; Rats; Substance Withdrawal Syndrome; Tegmentum Mesencephali; Ventral Tegmental Area